Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 4
Moderate 13
Mild 14
None 12

Commonly reported side effects and conditions associated with Bortezomib

Side effect Patients Percentage
Fatigue 7
Constipation 4
Peripheral neuropathy 4
Chronic constipation 2
Dizziness 2
Neuropathy in feet 2

Show all 30 reported side effects

Why patients stopped taking Bortezomib

Multiple reasons could be selected

Reason Patients Percentage
Doctor's advice 13
Course of treatment ended 11
Side effects too severe 7
Other 4
Did not seem to work 3
See all 29 patients who've stopped taking Bortezomib

Duration

Stopped taking Bortezomib

Duration Patients Percentage
Less than 1 month 4
1 - 6 months 8
6 months - 1 year 7
1 - 2 years 5
2 - 5 years 5
Adherence
Adherence Evaluations Percentage
Always 41
Usually 0
Sometimes 0
Never taken as prescribed 2
Burden
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 4
A little hard to take 11
Not at all hard to take 28
Cost per month
Cost per month Evaluations Percentage
$200+ 1
$100-199 0
$50-99 3
$25-49 0
< $25 11
Not specified 28

What people switch to and from

Patients started taking Bortezomib after stopping:

Treatment Patients Percentage
Lenalidomide (Revlimid) 5
Lenalidomide-dexamethasone (Rd) 2
Bortezomib-lenalidomide-dexamethasone (VRd) 1
Dexamethasone (Decadron) 1

Patients stopped taking Bortezomib and switched to:

Treatment Patients Percentage
Carfilzomib (Kyprolis) 3
Lenalidomide (Revlimid) 3
Daratumumab (Darzalex) 2
Dexamethasone (Decadron) 1
Elotuzumab (Empliciti) 1

Show all 6 treatments patients report switching to

Last updated:
There are no evaluations for Bortezomib.